Lipids
Lipids(脂质)
- Acyl-CoAs(13)
- Cyclooxygenase(543)
- Endocannabinoid/Endocannabinoid-like(145)
- Fatty Acid Conjugates(11)
- Fatty Acids(498)
- Fatty Alcohols/Aldehydes(16)
- Fatty Amides(77)
- Fatty Esters/Ethers(152)
- Glycerolipids(357)
- Glycerophospholipids(272)
- Hydrocarbons(15)
- Hydroxy/Hydroperoxy/Epoxy/Oxo Eicosanoids(146)
- Isoprostanes(36)
- Leukotrienes(69)
- Lipid Transport(11)
- Lipid-Based Drug Delivery(163)
- Lipoxins/Resolvin Es(10)
- Octadecanoids(124)
- Other Lipid Kinases(2)
- P450
- Polyketides(71)
- Prenol Lipids(19)
- Prostaglandins(483)
- Protein Lipidation(24)
- Reactive O2/N2 Pathways(116)
- Saccharolipids(2)
- Sphingolipids(359)
- Sterol Lipids(288)
- Thromboxanes(14)
- 11β-HSD
- 17β-HSD(2)
Lipids 相关产品(3019)
- GC492067α-hydroxy DehydroepiandrosteroneCAS: 53-00-9纯度: >98.00%
An active metabolite of dehydroepiandrosterone
- GC49270Nicotinamide-d4CAS: 347841-88-7纯度: >99.00%
An internal standard for the quantification of nicotinamide
- GC49273Glycerophosphorylethanolamine (sodium salt)CAS: 883288-78-6纯度: >90.00%
An active metabolite of phosphatidylethanolamine
- GC492941-(4-Chlorobenzhydryl)piperazineCAS: 303-26-4纯度: >98.00%
An inactive metabolite of meclizine and chlorcyclizine
- GC492987α-ThiomethylspironolactoneCAS: 38753-77-4纯度: >95.00%
A major metabolite of spironolactone
- GC49316O-Desmethyl-N-deschlorobenzoyl IndomethacinCAS: 50995-53-4纯度: >95.00%
A metabolite of indomethacin
- GC493265β-DihydroprogesteroneCAS: 128-23-4纯度: >95.00%
A progesterone receptor agonist and metabolite of progesterone
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC49183 | 6-hydroxy Etodolac | 101901-06-8 | >90.00% | |
A metabolite of etodolac | ||||
| GC49200 | Biotin (R)-Sulfoxide | 3376-83-8 | >98.00% | |
A metabolite of biotin | ||||
| GC49206 | 7α-hydroxy Dehydroepiandrosterone | 53-00-9 | >98.00% | |
An active metabolite of dehydroepiandrosterone | ||||
| GC49226 | CAY10787 | 567-72-6 | >95.00% | |
An oxysterol and a negative allosteric modulator of GABA A receptors | ||||
| GC49229 | Ganodermanontriol | 106518-63-2 | >90.00% | |
A triterpene with diverse biological activities | ||||
| GC49237 | 93-O17O | 2227214-78-8 | >98.00% | |
An ionizable cationic lipidoid | ||||
| GC49238 | 93-O17S | 2227008-67-3 | ≥95.00% | |
An ionizable cationic lipidoid | ||||
| GC49239 | Lipid 5 | 2089251-33-0 | >97.00% | |
Lipid 5是一种新型氨基脂质。 | ||||
| GC49263 | Ac2-26 (human) (ammonium salt) | - | >90.00% | |
An annexin A1-mimetic peptide | ||||
| GC49270 | Nicotinamide-d4 | 347841-88-7 | >99.00% | |
An internal standard for the quantification of nicotinamide | ||||
| GC49273 | Glycerophosphorylethanolamine (sodium salt) | 883288-78-6 | >90.00% | |
An active metabolite of phosphatidylethanolamine | ||||
| GC49279 | Resolvin D2 n-3 DPA | 2093111-29-4 | >98.00% | |
A specialized pro-resolving mediator | ||||
| GC49283 | 2-O-(α-D-Glucopyranosyl)glycerol | 22160-26-5 | >95.00% | |
A compatible solute | ||||
| GC49284 | GSK-A1 | 1416334-69-4 | >98.00% | |
A PI4KIIIα inhibitor | ||||
| GC49294 | 1-(4-Chlorobenzhydryl)piperazine | 303-26-4 | >98.00% | |
An inactive metabolite of meclizine and chlorcyclizine | ||||
| GC49298 | 7α-Thiomethylspironolactone | 38753-77-4 | >95.00% | |
A major metabolite of spironolactone | ||||
| GC49310 | 12-hydroxy Stearic Acid | 106-14-9 | >95.00% | |
A hydroxy fatty acid | ||||
| GC49315 | 5-hydroxy Indomethacin | 2504-32-7 | >98.00% | |
A metabolite of indomethacin | ||||
| GC49316 | O-Desmethyl-N-deschlorobenzoyl Indomethacin | 50995-53-4 | >95.00% | |
A metabolite of indomethacin | ||||
| GC49317 | 11(Z)-Docosenoic Acid | 1002-96-6 | >98.00% | |
A 22-carbon monounsaturated fatty acid | ||||
| GC49323 | Norcholic Acid | 60696-62-0 | >95.00% | |
A bile acid and derivative of cholic acid | ||||
| GC49325 | Dihydroxyacetone Phosphate (magnesium salt hydrate) | - | >95.00% | |
甘油脂前体 | ||||
| GC49326 | 5β-Dihydroprogesterone | 128-23-4 | >95.00% | |
A progesterone receptor agonist and metabolite of progesterone | ||||
| GC49327 | DPPE-MPEG(2000) | 459429-07-3 | >98.00% | |
A PEGylated form of DPPE | ||||